| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | RAGE Biotech Pty Ltd is a pharmaceutical start-up company developing novel therapeutics for patients with difficult-to-treat inflammatory disease. With our proprietary RNA therapeutics and peptide technologies, we are developing drugs targeting the Receptor for Advanced Glycation End-products (RAGE), a clinically important, pro-inflammatory ‘sensing' receptor. Our most advanced programme is an inhaled drug for lung diseases where inflammation is a problem. RAGE Biotech was formed in 2020 with investments from IP Group, Monash Investment Holdings, the University of Western Australia and the Perron Instute. |
| Category: | Hardware & devices, Health & biotech |
| URL: | http://ragebiotech.com |
| Operational Status: | |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2020 |
| Address: | Melbourne, AU |
| State: | Victoria |
| Overseas Operations: | |
| X: | |
| Facebook: | |
| Linkedin: | https://linkedin.com/company/rage-biotech |
| Founders: |
No items found
|
| Awards won: | |
